广东豪瑞恩制药

Haoruien Pharmaceutical is a specialty pharmaceutical company headquartered in Zhongshan, China, dedicated to the research, development, and production of complex drug delivery systems. The company focuses primarily on high-entry-barrier fields such as inhalation preparations for respiratory diseases and advanced ophthalmic formulations. Haoruien has established a robust technology platform for dry powder inhalers (DPI) and metered-dose inhalers (MDI), aiming to break the monopoly of international pharmaceutical giants in the Chinese respiratory market. Their product portfolio includes treatments for asthma, chronic obstructive pulmonary disease (COPD), and dry eye syndrome. With state-of-the-art GMP manufacturing facilities, the company provides high-quality generic and innovative therapeutic solutions. Haoruien continues to expand its pipeline through internal R&D and strategic collaborations to address unmet medical needs in chronic disease management.